Eliquis, a widely prescribed anticoagulant, is currently protected by several patents. However, the exact expiration dates can vary due to different patent types and legal challenges.
When Does Eliquis's Main Patent Expire?
The primary compound patent for apixaban, the active ingredient in Eliquis, was set to expire in the United States in 2026 [1]. This patent is held by Bristol Myers Squibb and Pfizer [1].
What About Other Patents for Eliquis?
Beyond the compound patent, there are numerous method-of-use and formulation patents for Eliquis that extend further into the future, some potentially lasting until 2031 [2]. These additional patents cover specific applications and ways the drug is manufactured or administered [2].
Can Generic Eliquis Be Available Before 2026?
The availability of generic versions of Eliquis before 2026 hinges on the outcome of patent litigation. Companies often challenge existing patents to pave the way for generic entry [3]. If these challenges are successful, or if settlements are reached, generic apixaban could potentially become available earlier than the expiration of the primary patent.
Who Owns the Patents for Eliquis?
Eliquis is jointly developed and marketed by Bristol Myers Squibb and Pfizer [1]. They are the primary holders of the patents protecting the drug [1].
What Happens After Eliquis's Patents Expire?
Once the key patents expire and any ongoing litigation is resolved, generic manufacturers will be able to produce and market their own versions of apixaban [3]. This typically leads to a significant decrease in the drug's price.
How Does Patent Expiration Affect Drug Pricing?
Patent expiration is a crucial factor in reducing medication costs. As generic alternatives enter the market, competition increases, forcing prices down for both consumers and healthcare systems [3].
What Are the Risks Associated with Generic Drug Entry?
While generic drugs offer cost savings, regulatory bodies ensure they are therapeutically equivalent to their brand-name counterparts. However, some patients and physicians may have concerns about the efficacy or formulation of generics compared to the originator drug, though rigorous testing is mandated [3].
Where Can I Find More Detailed Patent Information?
Detailed information on drug patents, including expiration dates and ongoing legal challenges, can be found on specialized databases like DrugPatentWatch.com [2].
*
**Sources:
[1] https://drugpatentwatch.com/drug/apixaban/patent/176630
[2] https://drugpatentwatch.com/drug/apixaban
[3] https://www.drugpatentwatch.com